Stereotaxis (STXS): Price and Financial Metrics
STXS Price/Volume Stats
| Current price | $2.15 | 52-week high | $3.29 |
| Prev. close | $2.11 | 52-week low | $1.40 |
| Day low | $2.12 | Volume | 44,893 |
| Day high | $2.17 | Avg. volume | 311,744 |
| 50-day MA | $1.99 | Dividend yield | N/A |
| 200-day MA | $2.16 | Market Cap | 177.68M |
STXS Stock Price Chart Interactive Chart >
Stereotaxis (STXS) Company Bio
Stereotaxis Inc. designs, manufactures, and markets advanced cardiology instrument control system for use in the cath lab that is used in the treatment of coronary artery disease and arrhythmias. The Company markets Stereotaxis System in the United States and Europe.
Latest STXS News From Around the Web
Below are the latest news stories about STEREOTAXIS INC that investors may wish to consider to help them evaluate STXS as an investment opportunity.
Baptist Health Lexington Enhances 20-Year Leadership in Pioneering Advanced Robotic Technology for Heart Disease PatientsLEXINGTON, Ky. and ST. LOUIS, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer in surgical robotics for minimally invasive endovascular intervention, and Baptist Health Lexington, a leading health provider in Kentucky, today announced that physicians have built upon their two-decades of leadership in robotic heart care with the successful treatment of first patients using the newest advancement in the technology, the Genesis Robotic Magnetic Navigation (RMN) System. Electrop |
Stereotaxis to Participate in Piper Sandler 35th Annual Healthcare ConferenceST. LOUIS, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that David Fischel, Chairman and CEO, will participate in the Piper Sandler 35th Annual Healthcare Conference. Mr. Fischel will present on Stereotaxis’ business and technology during a Fireside Discussion on Thursday, November 30, 2023, at 1:30 pm ET. Mr. Fischel will be available for one-on-one meetings that sam |
Stereotaxis, Inc. (AMEX:STXS) Q3 2023 Earnings Call TranscriptStereotaxis, Inc. (AMEX:STXS) Q3 2023 Earnings Call Transcript November 9, 2023 Stereotaxis, Inc. misses on earnings expectations. Reported EPS is $-0.07 EPS, expectations were $-0.05. Operator: Good morning. Thank you for joining us for Stereotaxis’ Third Quarter 2023 Earnings Conference Call. Certain statements during the conference call and question-and-answer period to follow may relate to […] |
Q3 2023 Stereotaxis Inc Earnings CallQ3 2023 Stereotaxis Inc Earnings Call |
Stereotaxis Inc (STXS) Reports Modest Revenue Growth in Q3 2023 Amid Strategic AdvancesFinancial Discipline and Innovation Strategy Drive Third Quarter Results |
STXS Price Returns
| 1-mo | 14.97% |
| 3-mo | 9.14% |
| 6-mo | -13.65% |
| 1-year | 27.22% |
| 3-year | -63.18% |
| 5-year | -38.87% |
| YTD | 22.86% |
| 2023 | -15.46% |
| 2022 | -66.61% |
| 2021 | 21.81% |
| 2020 | -3.78% |
| 2019 | 389.36% |
Continue Researching STXS
Want to see what other sources are saying about Stereotaxis Inc's financials and stock price? Try the links below:Stereotaxis Inc (STXS) Stock Price | Nasdaq
Stereotaxis Inc (STXS) Stock Quote, History and News - Yahoo Finance
Stereotaxis Inc (STXS) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...